No headlines found.
Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting
ACCESS Newswire (Wed, 28-Jan 8:30 AM ET)
ACCESS Newswire (Mon, 26-Jan 10:10 AM ET)
ACCESS Newswire (Fri, 23-Jan 2:51 PM ET)
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
Globe Newswire (Wed, 21-Jan 7:00 AM ET)
Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference
ACCESS Newswire (Tue, 20-Jan 5:50 PM ET)
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream
Globe Newswire (Tue, 20-Jan 7:00 AM ET)
ACCESS Newswire (Thu, 11-Dec 9:45 AM ET)
Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome
ACCESS Newswire (Tue, 18-Nov 8:30 AM ET)
Tivic Reports Third Quarter 2025 Financial Results
ACCESS Newswire (Fri, 14-Nov 4:30 PM ET)
ACCESS Newswire (Thu, 13-Nov 8:30 AM ET)
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Tivic Health Systems trades on the NASDAQ stock market under the symbol TIVC.
As of January 30, 2026, TIVC stock price declined to $1.19 with 37,629 million shares trading.
TIVC has a beta of 1.48, meaning it tends to be more sensitive to market movements. TIVC has a correlation of 0.02 to the broad based SPY ETF.
TIVC has a market cap of $2.10 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, TIVC traded as high as $1,444.83 and as low as $1.16.
The top ETF exchange traded funds that TIVC belongs to (by Net Assets): VXF.
TIVC has underperformed the market in the last year with a price return of -70.8% while the SPY ETF gained +15.6%. TIVC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -52.4% and -2.5%, respectively, while the SPY returned +2.1% and 0.0%, respectively.
TIVC support price is $1.17 and resistance is $1.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TIVC shares will trade within this expected range on the day.